title: Comments on meta-analysis of ivabradine as adjuvant treatment for chronic heart failure by Mizzaci et al.
authors.affiliation: Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden. Electronic address: karl.swedberg@gu.se.
authors.forename: Karl
authors.initials: K
authors.lastname: Swedberg
authors.affiliation: Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Homburg, Saar, Germany.
authors.forename: Michael
authors.initials: M
authors.lastname: Böhm
authors.affiliation: Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
authors.forename: Jeffrey S
authors.initials: JS
authors.lastname: Borer
authors.affiliation: Division of Cardiovascular Medicine and the Howard Gilman Institute for Heart Valve Disease and the Schiavone Institute for Cardiovascular Translational Research, State University of New York Downstate Medical Center, New York, NY, USA.
authors.forename: Ian
authors.initials: I
authors.lastname: Ford
authors.affiliation: Institute of Cardiometabolism and Nutrition (ICAN), Pierre et Marie Curie Paris VI University, La Pitié-Salpétrière Hospital, Paris, France.
authors.forename: Michel
authors.initials: M
authors.lastname: Komajda
authors.affiliation: Maria Cecilia Hospital, GVM Care and Research, Ettore Sansavini Health Science Foundation, Cotignola, Italy.
authors.forename: Luigi
authors.initials: L
authors.lastname: Tavazzi
keywords: Heart failure; Ivabradine; Treatment